Alembic Pharma received USFDA approval for diabetes drug

Posted on:17 Oct 2018 11:27:42
Alembic Pharma received USFDA approval for diabetes drug
17 October 2018 Current Affairs:

Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.

 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.


Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.

 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.


Monthly Current Affairs

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Currentt Affairs 2018 November

20 NOVEMBER
NEWS
19 NOVEMBER
NEWS
18 NOVEMBER
NEWS
17 NOVEMBER
NEWS

Currentt Affairs 2018 October

31 OCTOBER
NEWS
30 OCTOBER
NEWS
29 OCTOBER
NEWS
28 OCTOBER
NEWS

Currentt Affairs 2018 September

30 SEPTEMBER
NEWS
29 SEPTEMBER
NEWS
28 SEPTEMBER
NEWS
27 SEPTEMBER
NEWS